Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Histone hypoacetylation contributes to CXCL12 downregulation in colon cancer: impact on tumor growth and cell migration.

Romain B, Benbrika-Nehmar R, Marisa L, Legrain M, Lobstein V, Oravecz A, Poidevin L, Bour C, Freund JN, Duluc I, Guenot D, Pencreach E.

Oncotarget. 2017 Jun 13;8(24):38351-38366. doi: 10.18632/oncotarget.16323.

2.

SLC5A8 gene, a transporter of butyrate: a gut flora metabolite, is frequently methylated in African American colon adenomas.

Brim H, Kumar K, Nazarian J, Hathout Y, Jafarian A, Lee E, Green W, Smoot D, Park J, Nouraie M, Ashktorab H.

PLoS One. 2011;6(6):e20216. doi: 10.1371/journal.pone.0020216. Epub 2011 Jun 8.

3.

Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.

Yu J, Ma X, Cheung KF, Li X, Tian L, Wang S, Wu CW, Wu WK, He M, Wang M, Ng SS, Sung JJ.

Oncogene. 2010 Dec 9;29(49):6464-74. doi: 10.1038/onc.2010.370. Epub 2010 Aug 30.

PMID:
20802524
4.

Downregulation of the CXCR4/CXCL12 axis blocks the activation of the Wnt/β-catenin pathway in human colon cancer cells.

Song ZY, Gao ZH, Chu JH, Han XZ, Qu XJ.

Biomed Pharmacother. 2015 Apr;71:46-52. doi: 10.1016/j.biopha.2015.01.020. Epub 2015 Jan 15.

PMID:
25960214
5.
6.

Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer.

Ramos EA, Grochoski M, Braun-Prado K, Seniski GG, Cavalli IJ, Ribeiro EM, Camargo AA, Costa FF, Klassen G.

PLoS One. 2011;6(12):e29461. doi: 10.1371/journal.pone.0029461. Epub 2011 Dec 29.

7.

Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas.

Zhou W, Jiang Z, Liu N, Xu F, Wen P, Liu Y, Zhong W, Song X, Chang X, Zhang X, Wei G, Yu J.

J Cancer Res Clin Oncol. 2009 Jan;135(1):91-102. doi: 10.1007/s00432-008-0435-x. Epub 2008 Aug 1.

PMID:
18670789
8.

[Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].

Chen YX, Fang JY, Lu J, Qiu DK.

Zhonghua Yi Xue Za Zhi. 2004 Feb 17;84(4):312-7. Chinese.

PMID:
15059516
9.

Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms.

Li VS, Yuen ST, Chan TL, Yan HH, Law WL, Yeung BH, Chan AS, Tsui WY, So S, Chen X, Leung SY.

Gastroenterology. 2009 Jul;137(1):176-87. doi: 10.1053/j.gastro.2009.03.005. Epub 2009 Mar 18.

PMID:
19303019
10.

Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.

Algamas-Dimantov A, Yehuda-Shnaidman E, Peri I, Schwartz B.

Cell Oncol (Dordr). 2013 Apr;36(2):155-67. doi: 10.1007/s13402-012-0123-3. Epub 2013 Jan 11.

PMID:
23307400
11.

Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer.

Ramos EA, Camargo AA, Braun K, Slowik R, Cavalli IJ, Ribeiro EM, Pedrosa Fde O, de Souza EM, Costa FF, Klassen G.

BMC Cancer. 2010 Jan 28;10:23. doi: 10.1186/1471-2407-10-23.

12.

Global histone H4 acetylation and HDAC2 expression in colon adenoma and carcinoma.

Ashktorab H, Belgrave K, Hosseinkhah F, Brim H, Nouraie M, Takkikto M, Hewitt S, Lee EL, Dashwood RH, Smoot D.

Dig Dis Sci. 2009 Oct;54(10):2109-17. doi: 10.1007/s10620-008-0601-7. Epub 2008 Dec 5.

13.

3,3'-diindolylmethane enhances the efficacy of butyrate in colon cancer prevention through down-regulation of survivin.

Bhatnagar N, Li X, Chen Y, Zhou X, Garrett SH, Guo B.

Cancer Prev Res (Phila). 2009 Jun;2(6):581-9. doi: 10.1158/1940-6207.CAPR-08-0142. Epub 2009 May 26.

14.

Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue.

Yan DW, Fan JW, Yu ZH, Li MX, Wen YG, Li DW, Zhou CZ, Wang XL, Wang Q, Tang HM, Peng ZH.

Biochim Biophys Acta. 2012 Jun;1822(6):918-26. doi: 10.1016/j.bbadis.2012.02.021. Epub 2012 Mar 9.

15.
16.

Regulation of VDR Expression in Apc-Mutant Mice, Human Colon Cancers and Adenomas.

Giardina C, Nakanishi M, Khan A, Kuratnik A, Xu W, Brenner B, Rosenberg DW.

Cancer Prev Res (Phila). 2015 May;8(5):387-99. doi: 10.1158/1940-6207.CAPR-14-0371. Epub 2015 Apr 14.

17.

Epigenetic silencing of CHD5, a novel tumor-suppressor gene, occurs in early colorectal cancer stages.

Fatemi M, Paul TA, Brodeur GM, Shokrani B, Brim H, Ashktorab H.

Cancer. 2014 Jan 15;120(2):172-80. doi: 10.1002/cncr.28316. Epub 2013 Nov 14.

18.

DNA methylation alterations of AXIN2 in serrated adenomas and colon carcinomas with microsatellite instability.

Muto Y, Maeda T, Suzuki K, Kato T, Watanabe F, Kamiyama H, Saito M, Koizumi K, Miyaki Y, Konishi F, Alonso S, Perucho M, Rikiyama T.

BMC Cancer. 2014 Jun 25;14:466. doi: 10.1186/1471-2407-14-466.

19.

Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.

Zhou W, Jiang Z, Song X, Liu Y, Wen P, Guo Y, Xu F, Kong L, Zhang P, Han A, Yu J.

J Neurosci Res. 2008 Oct;86(13):3002-10. doi: 10.1002/jnr.21746.

PMID:
18512766
20.

CXCL12 is a key regulator in tumor microenvironment of cervical cancer: an in vitro study.

Yadav SS, Prasad SB, Prasad CB, Pandey LK, Pradhan S, Singh S, Narayan G.

Clin Exp Metastasis. 2016 Jun;33(5):431-9. doi: 10.1007/s10585-016-9787-9. Epub 2016 Mar 12.

PMID:
26970955

Supplemental Content

Support Center